Skip to main content
. 2018 Jun 7;18(2):1369–1376. doi: 10.3892/mmr.2018.9149

Figure 3.

Figure 3.

Trans-anethole treatment inhibits (A) eosinophil and (B) monocyte cell level in BALF in mice. Statistics were displayed as the mean ± standard deviation (n=5). *P<0.05 vs. control; #P<0.05 vs. model. BALF, bronchoalveolar lavage fluid; DXM, Dexamethasone.